The White House has invited members of Congress and others to a 3 p.m. ceremony today for the signing of an executive order (EO) on prescription drug pricing. We know this continues to be a hot political issue, but a key part of the EO reportedly involves importing price controls from countries with government-run health systems and using them as a basis for U.S. drug … [Read more...] about The IPI Won’t Fly
Recommendations for Trump’s second-term health care agenda
By Brian Blase and Lanhee ChenThe Washington Times, July 22, 2020 | President Trump has an opportunity to offer a second-term agenda that builds on his administration’s successes to expand families’ control over their health care. Given the importance that Americans place on health care issues for their vote, Mr. Trump probably can’t win reelection without doing so, Blase and Chen … [Read more...] about Recommendations for Trump’s second-term health care agenda
A Health Agenda for Congress—Brian Blase in Forbes
Galen Senior Fellow Brian Blase offers recommendations for Congress on health reform, detailing four priorities Congress should enact and two prominent proposals to avoid. Here is a quick overview of his latest piece in Forbes, “What Congress Should and Should Not Do on Health Care.” Congress should: codify the Trump administration’s price transparency rulesprohibit balance … [Read more...] about A Health Agenda for Congress—Brian Blase in Forbes
In 3 Charts, What to Know About Florida’s COVID-19 Surge
By Doug Badger, The Daily Signal, 07/15/20 | Florida reported almost as many COVID cases among its residents in the first two weeks of July as it did over the previous three and a half months. The newly infected population has trended younger, which is an encouraging sign. Those aged 15 to 54 account for more than two-thirds of all infections. That has helped reduce the percentage of … [Read more...] about In 3 Charts, What to Know About Florida’s COVID-19 Surge
Madam Speaker, Listen To The Experts—Op-Ed In NY Post
Why Congress must say no to the $600 unemployment bonus extensionBy Brian Blase, Casey Mulligan and Doug BadgerNew York Post, July 11, 2020 | House Speaker Nancy Pelosi demanded again today that Congress extend the federal unemployment bonus beyond its July 31 expiration. Former White House economists Brian Blase, Casey Mulligan, and Doug Badger explained … [Read more...] about Madam Speaker, Listen To The Experts—Op-Ed In NY Post
Getting America Back to Work and Hastening the Recovery
By Brian Blase, Casey Mulligan and Doug Badger | Three former White House economic advisers warn in a paper released today by the Galen Institute that Congress would delay the recovery if it extends the $600 weekly increase in unemployment insurance (UI) benefits scheduled to expire July 31. In their paper, “Getting America Back to Work and Hastening the Recovery,” they estimate that … [Read more...] about Getting America Back to Work and Hastening the Recovery
It’s time to ban balance billing
Negotiations to end surprise billing have been at an impasse for nearly a year. Discussions between the White House and congressional leaders over another coronavirus bill offer an opportunity to finally end this practice that defrauds millions of patients every year. The lobbying battle lines are well defined. On one side stand the private equity firms that have bought medical staffing agencies … [Read more...] about It’s time to ban balance billing
Potential Long-Term Economic Consequences of the Federal Response to the COVID-19 Lockdowns
Government imposition of widespread lockdowns in response to the COVID-19 pandemic have produced profound economic dislocations. Congress has sought to mitigate this economic damage by enacting a series of bills that have raised federal spending, deficits, and debt to extraordinary levels. Current deficits and debt are instructive, but insufficient, measures of a government’s financial … [Read more...] about Potential Long-Term Economic Consequences of the Federal Response to the COVID-19 Lockdowns